awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39255218-1E44A6AF-C6E7-4ACB-B739-32D5453CB97E
Q39255218-1E44A6AF-C6E7-4ACB-B739-32D5453CB97E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-1E44A6AF-C6E7-4ACB-B739-32D5453CB97E
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy.
P2860
Q39255218-1E44A6AF-C6E7-4ACB-B739-32D5453CB97E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-1E44A6AF-C6E7-4ACB-B739-32D5453CB97E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a4057ecd1bb86321da419205b57f1c05eecca70
P2860
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth